# Once Daily 3TC, Efavirenz and ddI for HIV Infection

> **NCT00214435** · PHASE4 · UNKNOWN · sponsor: **407 Doctors** · enrollment: 120 (—)

## Conditions studied

- HIV Infection
- AIDS

## Interventions

- **DRUG:** once daily minimum 3-drug regimen of anti-retroviral medications

## Key facts

- **NCT ID:** NCT00214435
- **Lead sponsor:** 407 Doctors
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 120 (—)
- **Last updated:** 2005-10-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214435, "Once Daily 3TC, Efavirenz and ddI for HIV Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00214435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*